150 related articles for article (PubMed ID: 32784393)
1. Promises of Fibroblast Growth Factor Receptor-Directed Therapy in Tailored Cancer Treatment.
Fagoonee S; Pellicano R
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32784393
[TBL] [Abstract][Full Text] [Related]
2. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
Sootome H; Fujita H; Ito K; Ochiiwa H; Fujioka Y; Ito K; Miura A; Sagara T; Ito S; Ohsawa H; Otsuki S; Funabashi K; Yashiro M; Matsuo K; Yonekura K; Hirai H
Cancer Res; 2020 Nov; 80(22):4986-4997. PubMed ID: 32973082
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.
Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D
J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptors in breast cancer.
Wang S; Ding Z
Tumour Biol; 2017 May; 39(5):1010428317698370. PubMed ID: 28459213
[TBL] [Abstract][Full Text] [Related]
6. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.
Zhu H; Ramnarayan K; Anchin J; Miao WY; Sereno A; Millman L; Zheng J; Balaji VN; Wolff ME
J Biol Chem; 1995 Sep; 270(37):21869-74. PubMed ID: 7665610
[TBL] [Abstract][Full Text] [Related]
7. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistance.
Davol PA; Frackelton AR
Prostate; 1999 Aug; 40(3):178-91. PubMed ID: 10398280
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.
Labanca E; Yang J; Shepherd PDA; Wan X; Starbuck MW; Guerra LD; Anselmino N; Bizzotto JA; Dong J; Chinnaiyan AM; Ravoori MK; Kundra V; Broom BM; Corn PG; Troncoso P; Gueron G; Logothethis CJ; Navone NM
Eur Urol Oncol; 2022 Apr; 5(2):164-175. PubMed ID: 34774481
[TBL] [Abstract][Full Text] [Related]
9. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
[TBL] [Abstract][Full Text] [Related]
10. Identification of two new hydrophobic residues on basic fibroblast growth factor important for fibroblast growth factor receptor binding.
Zhu H; Ramnarayan K; Menzel P; Miao Y; Zheng J; Mong S
Protein Eng; 1998 Oct; 11(10):937-40. PubMed ID: 9862214
[TBL] [Abstract][Full Text] [Related]
11. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities.
Reich-Slotky R; Shaoul E; Berman B; Graziani G; Ron D
J Biol Chem; 1995 Dec; 270(50):29813-8. PubMed ID: 8530375
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2 suppresses the expression of C-C motif chemokine 11 through the c-Jun N-terminal kinase pathway in human dental pulp-derived mesenchymal stem cells.
Kurogoushi R; Hasegawa T; Akazawa Y; Iwata K; Sugimoto A; Yamaguchi-Ueda K; Miyazaki A; Narwidina A; Kawarabayashi K; Kitamura T; Nakagawa H; Iwasaki T; Iwamoto T
Exp Ther Med; 2021 Dec; 22(6):1356. PubMed ID: 34659502
[TBL] [Abstract][Full Text] [Related]
13. Ionizing Radiation and Estrogen Affecting Growth Factor Genes in an Experimental Breast Cancer Model.
Calaf GM; Crispin LA; Muñoz JP; Aguayo F; Roy D; Narayan G
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430763
[TBL] [Abstract][Full Text] [Related]
14. Tumor models for prostate cancer exemplified by fibroblast growth factor 8-induced tumorigenesis and tumor progression.
Tuomela J; Härkönen P
Reprod Biol; 2014 Mar; 14(1):16-24. PubMed ID: 24607251
[TBL] [Abstract][Full Text] [Related]
15. Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.
Chell V; Balmanno K; Little AS; Wilson M; Andrews S; Blockley L; Hampson M; Gavine PR; Cook SJ
Oncogene; 2013 Jun; 32(25):3059-70. PubMed ID: 22869148
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.
Meijer D; Sieuwerts AM; Look MP; van Agthoven T; Foekens JA; Dorssers LC
Endocr Relat Cancer; 2008 Mar; 15(1):101-11. PubMed ID: 18310279
[TBL] [Abstract][Full Text] [Related]
17. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
18. Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma.
Lyou Y; Grivas P; Rosenberg JE; Hoffman-Censits J; Quinn DI; P Petrylak D; Galsky M; Vaishampayan U; De Giorgi U; Gupta S; Burris H; Rearden J; Li A; Wang H; Reyes M; Moran S; Daneshmand S; Bajorin D; Pal SK
Eur Urol; 2020 Dec; 78(6):916-924. PubMed ID: 32847703
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Koole K; van Kempen PM; Swartz JE; Peeters T; van Diest PJ; Koole R; van Es RJ; Willems SM
Cancer Med; 2016 Feb; 5(2):275-84. PubMed ID: 26711175
[TBL] [Abstract][Full Text] [Related]
20. Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.
Heinzle C; Sutterlüty H; Grusch M; Grasl-Kraupp B; Berger W; Marian B
Expert Opin Ther Targets; 2011 Jul; 15(7):829-46. PubMed ID: 21375471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
